A novel mechanism of antitumor response involving the expansion of cd3+/cd56+ large granular lymphocytes triggered by a tumor-expressed activating ligand

Leukemia

Volumn 16, Issue 5, 2002, Pages 855-860

  Costello, R T ^a,d   Sivori, S ^d   Mallet, F ^a   Sainty, D ^a   Arnoulet, C ^a   Reviron, D ^b   Gastaut, J A ^a   Moretta, A ^d   Olive, D ^a,c  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INSERM   (France)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Anti tumor immune response; Large granular lymphocytes; Leukemia; Natural killer receptors

Indexed keywords

BUSULFAN; CD3 ANTIGEN; CD48 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CELL RECEPTOR; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELPHALAN; METHOTREXATE; STEROID; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CASE REPORT; CELL MEDIATED CYTOTOXICITY; CLONAL VARIATION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LARGE GRANULAR LYMPHOCYTE; LEUKEMIA CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0036100199     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402488     Document Type: Article

References (37)

1. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency
2. Expansion of Philadelphia chromosome-negative CD3+CD56+ cytotoxic cells from chronic myeloid leukemia patients: In vitro and in vivo efficacy in severe combined immunodeficiency disease mice
3. Cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression
4. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes
5. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function
6. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients
7. HLA class I-specific inhibitory receptors in human T lymphocytes: Interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells
8. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: Impairment of specific cytolytic functions
9. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations
10. HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells
11. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: Molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells
12. Expression of HLA class I-specific inhibitory receptors by chronically activated cytolytic T lymphocytes: Useful or harmful to the host?
13. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell production
14. Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans
15. Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell response
16. Expression of HLA class I-specific inhibitory receptors in human cytotoxic T lymphocytes: A regulated mechanism that controls T-cell activation and function
17. + effector ab T cells
18. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells
19. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
20. 2B4-mediated activation of human natural killer cells
21. Proposed revised criteria for the classification of acute myeloid leukemia
22. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate
23. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells
24. 2B4 functions as a co-receptor in human NK cell activation
25. Acute myeloid leukemia triggering via CD40 induces leukocyte chemoattraction an cytotoxicity against allogenic or autologous leukemic targets
26. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition
27. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium
28. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells
29. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB
30. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
31. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas
32. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes
33. TCT.1, a target molecule for gamma/delta T cells, is encoded by an immunoglobulin super-family gene (Blast-1) located in the CD1 region of human chromosome 1
34. Expression of the blast-1 activation/adhesion molecule and its identification as CD48
35. Activation of NK cells and non-MHC restricted T cells by a novel cell surface molecule
36. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery
37. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes